What is it about?

Throughout one’s lifetime, muscles are injured upon constant usage in day to day activities. Damaged cells within the injured muscle require efficient replacement in order to improve the healing process; this process is called muscle regeneration. Muscle regeneration requires the presence of quiescent muscle stem cells that will ensure both the maintenance of the pool and the regeneration in response to injury. We identified the protein PRMT1, an enzyme catalyzing arginine methylation, as a key regulator of muscle stem cell fate. Using mouse as an animal model, we demonstrated that the specific ablation of PRMT1 in muscle stem cells prevents proper muscle regeneration but increases muscle stem cell expansion.

Featured Image

Why is it important?

Understanding how injured muscles undergo regeneration is a major area of interest in medicine as it could help develop treatments for many muscular diseases. A current challenge in regenerative medicine is to efficiently expand the muscle stem cells responsible for muscle regeneration. In this article, we found that depleting PRMT1 in muscle stem cells lead to a significant increase of the cell population expansion. We also found that the permanent depletion of the PRMT1 was preventing proper muscle regeneration. Finding the balance to control muscle stem cell fate and expansion is key to help develop stem cell based therapies in order to treat muscle dystrophies, and to prevent or delay aged-related muscle mass (sarcopenia).

Perspectives

In the near future, when PRMT1 inhibitor become available, PRMT1 could become a therapeutic target to efficiently expand muscle stem cells for stem cell-based therapies. Controlling muscle stem cell expansion is crucial to improve muscle regeneration in muscular pathologies such as Duchenne muscular dystrophy, or to improve muscle regeneration in elderly where the number of muscle stem cell is significantly decreased. These advancements may allow for a significant contribution to the field of regenerative medicine, especially for stem cell based therapies.

Romeo Blanc

Read the Original

This page is a summary of: Arginine Methylation by PRMT1 Regulates Muscle Stem Cell Fate, Molecular and Cellular Biology, November 2016, ASM Journals,
DOI: 10.1128/mcb.00457-16.
You can read the full text:

Read

Contributors

The following have contributed to this page